551 results on '"Iqbal, Zeenat"'
Search Results
152. Mesoporous Silica Nanoparticles: A Versatile Platform for Biomedical Applications
153. Co-delivery of gemcitabine and simvastatin through PLGA polymeric nanoparticles for the treatment of pancreatic cancer: in-vitro characterization, cellular uptake, and pharmacokinetic studies
154. Development of NIPAAm-PEG acrylate polymeric nanoparticles for co-delivery of paclitaxel with ellagic acid for the treatment of breast cancer
155. Optimization and Designing of Amikacin-loaded Poly d, l-Lactide-co-glycolide Nanoparticles for Effective and Sustained Drug Delivery
156. Development and optimization of erythromycin-loaded lipid-based gel by Taguchi design: In vitro characterization and antimicrobial evaluation
157. Novel 4-in-1 strategy to combat colon cancer, drug resistance and cancer relapse utilizing functionalized bioinspiring lignin nanoparticle
158. Contributors
159. Preparation of levofloxacin loaded in situ gel for sustained ocular delivery: in vitro and ex vivo evaluations.
160. Box-Behnken Design of Experiment Assisted Development and Optimization of Bendamustine HCl loaded Hydroxyapatite Nanoparticles
161. Polymeric nanoparticles as a platform for permeability enhancement of class III drug amikacin
162. Development of transethosomes formulation for dermal fisetin delivery: Box–Behnken design, optimization, in vitro skin penetration, vesicles–skin interaction and dermatokinetic studies
163. LYOPHILIZATION - PROCESS AND OPTIMIZATION FOR PHARMACEUTICALS
164. Retraction Note: An HPTLC Method for the Determination of Minocycline in Human Plasma, Saliva, and Gingival Fluid after Single Step Liquid Extraction
165. Development of Curcumin loaded chitosan polymer based nanoemulsion gel: In vitro, ex vivo evaluation and in vivo wound healing studies
166. Isolation, characterization, and quantification of curcuminoids and their comparative effects in cerebral ischemia
167. Biosimilars: Scientific Consideration and Regulatory Frameworks
168. Optimization and Designing of Amikacin-loaded Poly d, l-Lactide-co-glycolide Nanoparticles for Effective and Sustained Drug Delivery.
169. Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: In-vitroand ex-vivoinvestigations
170. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia
171. Quantification of Tamoxifen Polymeric Nanoparticles in female rodent breast tissue by UPLC/ESI-Q-TOF MS/MS
172. Quantification and evaluation of thymoquinone loaded mucoadhesive nanoemulsion for treatment of cerebral ischemia
173. Development and pharmacokinetic evaluation of spray-dried self-nanoemulsifying drug delivery system of sertraline
174. A vaginal drug delivery model
175. A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics
176. Investigative Approaches for Oral Delivery of Anticancer Drugs: A Patent Review
177. Investigation of ethosomes as surrogate carriers for bioactives
178. Revisiting the nanoformulation design approach for effective delivery of topotecan in its stable form: an appraisal of its in vitro Behavior and tumor amelioration potential
179. Mesoporous Silica Nanoparticles: A Versatile Platform for Biomedical Applications
180. Liquid chromatographic method for irinotecan estimation: Screening of p-gp modulators
181. RETRACTED ARTICLE: PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC/ESI-Q-ToF-MS/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model
182. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: anin vitro, ex vivoandin vivoinvestigations
183. Nanosuspension: A Potential Nanoformulation for Improved Delivery of Poorly Bioavailable Drug
184. Quantification of curcumin, demethoxycurcumin, and bisdemethoxycurcumin in rodent brain by UHPLC/ESI-Q-TOF-MS/MS after intra-nasal administration of curcuminoids loaded PNIPAM nanoparticles
185. Nanopotentiation of Propolis for Revocation of Enzyme Imbalance in UVB Induced Cutaneous Toxicity in Murine Model: a Preliminary Study for Chemoprotection of Skin Cancer
186. HPTLC METHOD FOR ANALYSIS OF SERTRALINE IN PURE BULK DRUG AND LIPIDIC NANO DELIVERY SYSTEM: A STRESS DEGRADATION STUDIES
187. Thymoquinone: Major Molecular Targets, Prominent Pharmacological Actions and Drug Delivery Concerns
188. Revisiting the nanoformulation design approach for effective delivery of topotecan in its stable form: an appraisal of its in vitro Behavior and tumor amelioration potential.
189. PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC/ESI-Q-ToF-MS/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model.
190. An Overview of the Regulatory and Developmental Strategies of Chronotherapeutics.
191. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
192. Solid Nanoemulsion Preconcentrate (NanOsorb) for Oral Delivery of Sertraline: Development and Characterization
193. In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
194. Particle Engineering in the Perspective of Thermodynamics: A Case Study with Itraconazole
195. Formulation, Antimicrobial and Toxicity Evaluation of Bioceramic based Ofloxacin Loaded Biodegradable Microspheres for Periodontal Infection
196. Role of CD44 in tumour progression and strategies for targeting
197. Estimation of sertraline by chromatographic (HPLC-UV273 nm) technique under hydrolytic stress conditions
198. QUANTITATIVE ANALYSIS OF ITRACONAZOLE IN BULK, MARKETED, AND NANO FORMULATION BY VALIDATED, STABILITY INDICATING HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY
199. Development and Validation of UHPLC/ESI-Q-TOF-MS Method for Terbutaline Estimations in Experimental Rodents: Stability Effects and Plasma Pharmacokinetics
200. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.